 - Any current or previous use of cyclosporin, tacrolimus, anti-TNF therapy, and other biologics, including anti-integrin antibodies approved or investigational, JAK inhibitors approved or investigational, or any current or previous use of an investigational agent within 5 half-lives of that agent before the first study agent injection. 